# TRUSCREEN GROUP LIMITED (NZX:TRU)

**Exchange:** NZX (XNZE)
**Sector:** Industrials
**ISIN:** NZTRUE0001S7
**Financial year-end:** March

## Overview

TruScreen develops and commercializes real-time cervical cancer screening technology that provides instant results without laboratory processing.

## Market

- **Market cap:** NZ$13.5M (most recent close)

## Latest annual results (FY2025)

- **Net profit:** NZ$-2.2M
- **EPS:** -0.41c
- **Total assets:** NZ$1.8M
- **Total equity:** NZ$1.0M
- **Return on equity:** -222.5%
- **Debt-to-equity:** 0.83

All figures sourced from the company's most recent annual report. Monetary values in New Zealand dollars.

## Governance

- **Governance Risk Score (NZXplorer methodology):** 68.97 — Good (calculated 2026-06-01T12:35:11.966+00:00)
- **Board size:** 8 directors, 50% independent
- **Chair:** [Anthony Ho](https://nzxplorer.co.nz/people/anthony-ho)

## Latest NZX announcement

- **Change of Auditors** (2026-05-06, AUDITORS)
- Source: https://www.nzx.com/announcements/472199

## More data

- Company page: https://nzxplorer.co.nz/companies/truscreen
- Structured facts (JSON): https://nzxplorer.co.nz/api/v1/companies/TRU/facts.json
- Full detail API: https://nzxplorer.co.nz/api/v1/companies/TRU?include=all
- Company website: https://www.truscreen.com
- NZX page: https://www.nzx.com/companies/TRU

---

Published by [NZXplorer](https://nzxplorer.co.nz). Canonical: https://nzxplorer.co.nz/companies/truscreen. Data licence: CC BY 4.0 with attribution to NZXplorer + NZX as primary disclosure source. Generated 2026-06-03.